Can recombinant growth hormone effectively treat idiopathic short stature?

Journal of Family Practice

Volumn 57, Issue 9, 2008, Pages 611-612

  Von Fange, Tim ^a   McDiarmid, Todd ^a   Mackler, Leslie ^b   Zolotor, Adam ^c  

^a Moses Cone Family Medicine Residency Program   (United States)

^b MOSES CONE HEALTH SYSTEM   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT GROWTH HORMONE; GROWTH HORMONE;

BODY HEIGHT; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; NOTE; PATIENT COMPLIANCE; SCORING SYSTEM; SHORT STATURE; TREATMENT DURATION; ARTICLE; DRUG EFFECT; GROWTH DISORDER;

BODY HEIGHT; GROWTH DISORDERS; GROWTH HORMONE; HUMANS;

EID: 51849114687     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (7)

1. Weise KL, Nahata MC. Growth hormone use in children with idiopathic short stature. Ann Pharmacother. 2004;38:1460-1468.
2. Bryant J, Cave C, Milne R. Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst Rev. 2003;(2):CD004440.
3. McCaughey ES, Mulligan J, Voss LD, et al. Randomised trial of growth hormone in short normal girls. Lancet. 1998;351:940-944.
4. Leschek EW, Rose SR, Yanovski JA, et al. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature; a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:3140-3148.
5. Humatrope for non-growth-hormone-deficient short stature. Briefing document from the Endocrinologic and Metabolic Drugs Advisory Committee. Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, June 10, 2003, volume 1.
6. FDA approves Humatrope for short stature. Available at: www.fda.gov/bbs/topics/ANSWERS/2003/ANS01242.html. Accessed June 12, 2008.
7. Wilson TA, Rose SR, Cohen P, et al. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr. 2003;143:415-421.